Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 8-K Event Delisting notice
  2. 10-K Report Annual Report
  3. 8-K Event Shareholder vote results
  4. 8-K Event Material agreement · Shareholder vote results
  5. 8-K Event Results of operations
  6. 10-Q Report Quarterly Report
  7. 8-K Event Bylaws or fiscal year change
  8. 8-K/A Event Material agreement
  9. 8-K Event Material agreement
  10. 8-K Event Executive or director change · Bylaws or fiscal year change
  11. 8-K/A Event Executive or director change · Other events
  12. 8-K Event Executive or director change · Other events
  13. 8-K Event Executive or director change
  14. 10-Q Report Quarterly Report
  15. 10-Q Report Quarterly Report
  16. 10-K/A Report 10-K/A
  17. 10-Q/A Report 10-Q/A
  18. 10-Q/A Report 10-Q/A
  19. 8-K Event Restatement
  20. 8-K Event Delisting notice

Page 9 of 12 · 228 filings